At the time of writing, Caredx Inc [CDNA] stock is trading at $23.34, up 4.52%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CDNA shares have gain 10.67% over the last week, with a monthly amount drifted -9.95%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Caredx Inc [NASDAQ: CDNA] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Underweight rating and assigned the stock a price target of $28. Previously, BTIG Research upgraded its rating to Buy on August 19, 2024, and kept the price target unchanged to $40. On May 13, 2024, downgrade downgraded it’s rating to Mkt Perform. Craig Hallum upgraded its rating to a Buy but stick to its price target of $15 on May 01, 2024. Stephens upgraded its rating to a Overweight but $10 remained the price target by the analyst firm on November 09, 2023. Raymond James upgraded its rating to Outperform for this stock on August 15, 2023, but kept the price target unchanged to $12. In a note dated May 11, 2023, BTIG Research downgraded an Neutral rating on this stock.
For the past year, the stock price of Caredx Inc fluctuated between $7.42 and $34.84. Currently, Wall Street analysts expect the stock to reach $37.5 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $23.34 at the most recent close of the market. An investor can expect a potential return of 60.67% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
According to Caredx Inc [NASDAQ:CDNA], the company’s sales were 312.77M for trailing twelve months, which represents an 23.35% jump. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -0.18%, Pretax Profit Margin comes in at -0.46%, and Net Profit Margin reading is -0.46%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.54 and Total Capital is -0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.44 points at the first support level, and at 21.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.81, and for the 2nd resistance point, it is at 24.27.
Ratios To Look Out For
It is important to note that Caredx Inc [NASDAQ:CDNA] has a current ratio of 4.10. Also, the Quick Ratio is 3.87, while the Cash Ratio stands at 1.17. Considering the valuation of this stock, the price to sales ratio is 4.15, the price to book ratio is 4.54.
Transactions by insiders
Recent insider trading involved Novack Jeffrey Adam, Secretary and General Counsel, that happened on Dec 04 ’24 when 1917.0 shares were sold. Officer, Jeffrey Adam Novack completed a deal on Dec 04 ’24 to buy 1917.0 shares. Meanwhile, Director Maag Peter sold 5000.0 shares on Nov 26 ’24.
